Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Cash Flows

v3.25.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Mar. 29, 2025
Mar. 30, 2024
Apr. 01, 2023
OPERATING ACTIVITIES      
Net income (loss) $ (189,716,000) $ (968,882,000) $ 118,584,000
Income (loss) from discontinued operations, net of tax (259,040,000) 49,595,000 (637,150,000)
Income (loss) from continuing operations, net of tax 69,324,000 (1,018,477,000) 755,734,000
Adjustments to reconcile net income (loss) to cash provided (used) by operating activities:      
Impairment of goodwill and intangible assets 89,242,000 507,566,000 0
Depreciation, amortization and other asset write-downs 259,616,000 307,528,000 251,926,000
Reduction in the carrying amount of right-of-use assets 351,971,000 379,720,000 369,609,000
Stock-based compensation 73,247,000 57,829,000 40,040,000
Provision for doubtful accounts 15,377,000 11,170,000 3,532,000
Pension expense in excess of (less than) contributions (1,463,000) (18,080,000) 79,197,000
Deferred income taxes (88,544,000) (383,916,000) 12,441,000
Write-off of income tax receivables and interest 0 921,409,000 0
Other, net (9,515,000) (2,138,000) (39,090,000)
Changes in operating assets and liabilities:      
Accounts receivable (100,803,000) 323,503,000 (141,684,000)
Inventories 54,102,000 521,281,000 (882,771,000)
Accounts payable (2,303,000) (111,992,000) 380,792,000
Income taxes 9,366,000 (156,198,000) (1,126,649,000)
Accrued liabilities 48,847,000 27,539,000 (16,079,000)
Operating lease right-of-use assets and liabilities (353,661,000) (374,063,000) (365,760,000)
Other assets and liabilities 23,686,000 (107,967,000) 24,778,000
Cash provided (used) by operating activities - continuing operations 438,489,000 884,714,000 (653,984,000)
Cash provided (used) by operating activities - discontinued operations 26,747,000 129,867,000 (1,811,000)
Cash provided (used) by operating activities 465,236,000 1,014,581,000 (655,795,000)
INVESTING ACTIVITIES      
Proceeds from sale of businesses, net of cash sold 1,506,223,000 0 0
Proceeds from sale of assets 88,234,000 26,525,000 99,481,000
Capital expenditures (86,274,000) (135,762,000) (151,990,000)
Software purchases (39,749,000) (61,483,000) (93,137,000)
Other, net (35,930,000) 12,038,000 (26,251,000)
Cash provided (used) by investing activities - continuing operations 1,432,504,000 (158,682,000) (171,897,000)
Cash used by investing activities - discontinued operations (4,413,000) (13,576,000) (16,156,000)
Cash provided (used) by investing activities 1,428,091,000 (172,258,000) (188,053,000)
FINANCING ACTIVITIES      
Contingent consideration payment 0 0 (56,976,000)
Net increase (decrease) in short-term borrowings (252,023,000) 255,146,000 (323,972,000)
Payments on long-term debt (1,751,109,000) (908,199,000) (501,051,000)
Payment of debt issuance costs 0 (576,000) (6,796,000)
Proceeds from long-term debt 0 0 2,058,341,000
Cash dividends paid (140,165,000) (303,140,000) (702,846,000)
Proceeds from issuance of Common Stock, net of payments for tax withholdings (2,730,000) (2,846,000) (2,794,000)
Cash provided (used) by financing activities (2,146,027,000) (959,615,000) 463,906,000
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash 7,218,000 (22,069,000) (80,822,000)
Net change in cash, cash equivalents and restricted cash (245,482,000) (139,361,000) (460,764,000)
Cash, cash equivalents and restricted cash — beginning of year 676,957,000 816,318,000 1,277,082,000
Cash, cash equivalents and restricted cash — end of year 431,475,000 676,957,000 816,318,000
Balances per Consolidated Balance Sheets:      
Cash and cash equivalents 429,382,000 656,376,000 799,441,000
Other current assets 2,093,000 2,221,000 1,305,000
Current and other assets of discontinued operations 0 18,351,000 15,563,000
Other assets 0 9,000 9,000
Total cash, cash equivalents and restricted cash $ 431,475,000 $ 676,957,000 $ 816,318,000